We’ve all heard the common question: “Do you want fries with that?”
Now, food brands are asking something else: “Do you want a side dish with your Ozempic?”
The use of weight loss medicines like Ozempic, Mounjaro, and Wegovy have exploded in the last year, and analysts estimate 7% of the US population (~24m people) will be taking the drugs by 2035.
And because the drugs can reduce calorie intake by up to 30% daily, it’s a trend food companies — and their investors — can’t ignore.
Brands are creating new products to keep up with shrinking consumer appetites, per The Wall Street Journal:
And protein shake and powder company BellRing Brands, which has seen revenue rise 22% in the last 12 months, is considering new formulations to include the micronutrients dieters need.
Other companies are taking a different approach with new products that mimic the effects of weight loss drugs, without the prescriptions and high prices.
Whether brands decide to tweak existing products, shrink portion sizes, or launch new, weight loss-friendly options, will likely depend on how many people adopt these drugs.
For now, we’re putting our money on Nestle releasing a protein KitKat.